The mitochondrial T1095C mutation increases gentamicin-mediated apoptosis

Mitochondrion. 2012 Jul;12(4):465-71. doi: 10.1016/j.mito.2012.06.006. Epub 2012 Jun 24.

Abstract

We have previously reported a heteroplasmic mtDNA mutation (T1095C) in the 12SrRNA gene of an Italian family with features of maternally-inherited parkinsonism, antibiotic-mediated deafness and peripheral neuropathy. In the present study, we demonstrate that a transmitochondrial cybrid line derived from the proband of this family shows selective depletion of mitochondrial glutathione and decreases in the activity of complex II/III. Moreover, when exposed to an aminoglycoside antibiotic these cells responded with a ten-fold increase in the number of apoptotic cells compared to controls. These results support a pathogenic role for the T1095C mutation and indicate that the mutation increases the risk for aminoglycoside-induced toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / toxicity
  • Apoptosis*
  • Cell Line
  • DNA, Mitochondrial / genetics*
  • Genes, rRNA
  • Gentamicins / adverse effects*
  • Gentamicins / metabolism
  • Gentamicins / toxicity
  • Humans
  • Italy
  • Mitochondria / drug effects*
  • Mitochondria / genetics*
  • Mitochondria / metabolism
  • Point Mutation*
  • RNA, Ribosomal / genetics

Substances

  • Anti-Bacterial Agents
  • DNA, Mitochondrial
  • Gentamicins
  • RNA, Ribosomal
  • RNA, ribosomal, 12S